The value of early intervention in psychosis and allocation of public resources has long been debated since outcomes in people with schizophrenia-spectrum disorders have remained suboptimal. Several research programs for early psychosis yielded promising results for teambased, multi-element coordinated specialty care (CSC). Methods: Systematic literature search of PubMed/PsycInfo/Embase/clinicaltrials.gov without language restrictions until 06/06/2017. Random effects meta-analysis of randomized trials comparing CSC versus Treatment as Usual (TAU) in in first episode psychosis or early-phase schizophreniaspectrum disorders (schizophrenia, psychotic disorder not otherwise specified, schizoaffective disorder, schizophreniform disorder, delusional disorder), calculating standardized mean differences (SMDs) and risk ratios (RRs) for continuous and categorical outcomes as well as prespecified subgroup and meta-regression analyses. Co-primary outcomes were all-cause treatment discontinuation and ≥1 psychiatric hospitalization during the treatment period. Key secondary outcomes were total symptom improvement, functioning, and work or school involvement. Results: Across 10 trials (n=2,176; age=27.5 ± 4.6 years; male=62.3%; trial duration=16.2 ± 7.4 (range=9-24) months), CSC outperformed TAU at the end of treatment regarding all meta-analyzable outcomes. This included all-cause discontinuation (studies=10, n=2,173, RR=0.70, 95% confidence interval (CI)=0.61-0.80, p<0.001; number-needed-to-treat (NNT)=12.4), ≥1 hospitalization (studies=10, n=2,105, RR=0.74, 95%CI=0.61-0.90, p=0.003; NNT=10.1), total symptom severity (studies=8, n=1,179, SMD=-0.32, 95%CI=-0.47, -0.17, p<0.001), positive symptoms (studies=10, n=1,532, SMD=-0.22, 95%CI=-0.32, -0.13, p<0.001), negative symptoms (studies=10, n=1,432, SMD=-0.28, 95%CI=-0.42, -0.14, p<0.001), general symptoms (studies=8, n=1,118, SMD=-0.30, 95%CI=-0.47, -0.13, p=0.001), depressive symptoms (studies=5, n=874, SMD=-0.19, p=0.017), functioning (studies=7, n=1,005, SMD=0.21, p=0.001), involvement in school/work (studies=6, n=1,743, RR=1.13, p=0.012; NNT=17.8), and quality of life (studies=4, n=505, SMD=0.23, p=0.046). Superiority of CSC regarding all outcomes was also evident at 6, 9-12, and 18-24 months of treatment (except general symptoms and depression at 18-24 months). Discussion: In early psychosis, CSC is superior to TAU across all meta-analyzable, highly relevant outcomes with small-to-medium effect sizes. These results support the need for funding and utilization of CSC in patients with early-phase psychosis.
O11.6. WHO GETS IN TO EARLY PSYCHOSIS INTERVENTION SERVICES? A COMPARISON OF SERVICE USERS AND NON-USERS IN HEALTH
Background: There is a dearth of information on people with first-episode psychosis who do not access specialized early psychosis intervention (EPI) services. With this notable gap in knowledge comes the implicit assumption that nearly all cases of first-episode psychosis are detected and treated by EPI services. We sought to estimate the proportion of incident cases of non-affective psychosis who do not access these services, and to examine factors associated with EPI admission. Methods: Using health administrative data, we constructed a retrospective cohort of incident cases of non-affective psychosis in the catchment area of the Prevention and Early Intervention Program for Psychoses (PEPP) in London, Ontario between 1997 and 2013. This cohort was linked to primary data from PEPP to identify EPI-users. We used multivariate logistic regression to model socio-demographic and service factors associated with EPI admission. Results: Over 50% of suspected cases of non-affective psychosis did not have contact with the EPI program for screening or admission. Our findings suggest a clear gradient by age, with a decreasing likelihood of being treated in the EPI program with increasing age strata (age 46-50 years vs. age 16-20 years: OR=0.03, 95%CI=0.01-0.05). EPI-users are more likely to be male (OR=1.58, 95%CI=1.24-2.01), and less likely to live in areas of socioeconomic deprivation (OR=0.51, 95%CI=0.36-0.73). EPI-users also had a higher odds of psychiatrist involvement at the index diagnosis (OR=7.35, 95%CI=5.43-10.00), had a lower odds of receiving the index diagnosis in an outpatient setting (OR=0.50, 95%CI=0.38-0.65), and had a lower odds of prior alcohol-related (OR=0.42, 95%CI=0.28-0.63) and substance-related (OR=0.68, 95%CI=0.50-0.93) disorders. Discussion: Much of the prior research on EPI services is predicated on the belief that nearly all patients with first-episode psychosis are represented in these services, with little discussion or consideration of people who may be receiving care elsewhere in the health system. We need greater consideration of patients with first-episode psychosis who are not accessing EPI services -our findings suggest this group is sizable, and there may be socio-demographic and clinical disparities in access. Non-psychiatric health professionals could be targeted with interventions aimed at increasing detection and referral rates. 
Columbia University & New York State Psychiatric Institute
Background: Individuals with mood and psychotic disorders treated in hospital psychiatric units have high rates of discontinuing treatment following discharge, a time that poses substantial risks of serious and even life threatening adverse outcomes. Hospital provider care transition practices believed to improve transitions include communication with outpatient providers, scheduling timely appointments for outpatient follow-up care, forwarding case summaries to aftercare providers, and involving family or support persons in discharge planning. While these are standards of care, little is known about how often they are adequately delivered and their impact on post-discharge aftercare adherence. Methods: As part of a larger project looking at over 30,000 hospital admissions of Medicaid patients with serious mental illness, this study examined hospital medical records for 217 admissions at two urban US hospitals. Trained raters reviewed records for evidence of inpatient providers completing discharge planning practices. Medicaid data were used to measure demographics and attendance of seven-and 30-day outpatient appointments. Results: The sample of 217 admissions was 51% male and 82% were adults, with discharge diagnoses including schizophrenia and related disorders (45%), bipolar disorders (28%) and depressive disorders (17%). The average length of stay was 14 ± 13 days with a median of nine days. The medical records showed evidence of inpatient providers communicating with outpatient providers 64% (n=139) of the time. There was evidence of an outpatient appointment scheduled within seven days of discharge for 81% (n=176) of the sample. A case summary was made available to the aftercare provider within one day of discharge for 66% (n=144) of the sample. Records showed that the inpatient team communicated with family members or support persons about the patient's post-discharge treatment plan for 53% (n=114) of the sample, and 36% (n=79) attended a family meeting or therapy session. Rates of attending an aftercare behavioral health appointment were 55% (n=120) at seven days post-discharge and 80% (n=174) for 30 days. Discussion: This study found varying rates of providers completing care transition practices. Only half of the sample had attended an aftercare appointment in the seven days post discharge, however the majority had attended an appointment by 30 days. Planned analyses will present demographic and clinical differences among those who received discharge planning activities and had family involvement. We will examine predictors of attending follow-up care and report the effectiveness of discharge planning practices. Findings will help inform strategies to improve care-coordination and discharge planning for individuals with serious mental illnesses treated in psychiatric hospitals.
O11.8. PREVALENCE AND PREDICTORS OF INTERVIEW-ASSESSED CLINICAL HIGH-RISK SYMPTOMS IN THE GENERAL POPULATION
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Background: In clinical samples, symptomatic ultra-high risk criteria and the basic symptom criterion "cognitive disturbances" perform well in predicting psychosis, and best when both approaches are combined. However, little-to-nothing is known about the prevalence, clinical relevance, and moderators of these clinical high risk (CHR) criteria and their constituent symptoms in the community. Methods: Regression analyses involved 2683 community participants (age 16-40 years; response rate: 63.4%). Semi-structured telephone interviews were performed by well-trained psychologists. Results: Lifetime and current CHR symptoms were reported by 21.1% and 13.8% of interviewees. Frequency of symptoms was mostly low, only 2.4% met any CHR criterion. A stepwise relationship underlay the association of the two types of CHR symptoms and criteria with the presence of mental disorders and functional deficits, with odds ratios being highest (7.4-31.8) when ultra-high risk and basic symptoms occurred together. Report of a family history of mental disorder generally increased risk for CHR symptoms. While younger age increased risk for basic symptoms, lifetime substance misuse and trauma increased risk for ultra-high risk symptoms. Discussion: Prevalence of CHR criteria was within the range to be expected from the prevalence rates of psychoses. Clinical relevance of both CHR symptoms and criteria increased in a stepwise manner from basic symptoms via ultrahigh risk symptoms to their combined presence, reinforcing the clinical utility of their combined use. The risk factors selectively associated with basic and ultrahigh risk symptoms seem to support developmental models relating basic symptoms to neurobiological and ultra-high risk symptoms to psychological factors.
